Compared with the cell lines established by Yamamoto and other research groups (Nockel et al. 2006; Yamamoto et al. 2018), the MTC was characterized not only by loss of function of p53 but also by a Cdh1 mutation background. Here, TP53 is linked to medullary thyroid gland carcinoma.